Research - Seoul, Seoul, South Korea
NuclixBio is a pre-clinical stage biopharmaceutical company dedicated to developing innovative nucleic acid therapeutics based on its own platform technologies as a novel treatment approach for "undruggable" targets and diseases.NuclixBio designed the Ribo-TaP™ platform by implementing the strategy of targeted protein degradation onto its proprietary circular RNA, ringRNA™. NuclixBio is located in Seoul, South Korea. For more information, please visit http://www.nuclixbio.com.
Gmail
Nginx
Mobile Friendly
YouTube